Fluid resuscitation increases inflammatory gene transcription after traumatic injury

Journal of Trauma - Injury, Infection and Critical Care

Volumn 61, Issue 2, 2006, Pages 300-308

  Watters, Jennifer M ^a,c   Tieu, Brandon H ^a   Todd, S Rob ^b   Jackson, Terisa ^a   Muller, Patrick J ^a   Malinoski, Darren ^a   Schreiber, Martin A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c L223A ^*  (United States)

Author keywords

Colloid; Crystalloid; Cytokines; Hemorrhagic shock; Hextend; Inflammation; Lactated Ringers; Resuscitation

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; HETASTARCH; INTERLEUKIN 6; RINGER LACTATE SOLUTION; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CRYSTALLOID; FLUID RESUSCITATION; GENETIC TRANSCRIPTION; HEMORRHAGIC SHOCK; IMMUNE RESPONSE; INJURY; MEAN ARTERIAL PRESSURE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; SWINE; TISSUE SECTION;

ANIMALS; COLLOIDS; CYTOKINES; DOUBLE-BLIND METHOD; FLUID THERAPY; HETASTARCH; INFLAMMATION; ISOTONIC SOLUTIONS; LUNG; NEUTROPHIL ACTIVATION; PLASMA SUBSTITUTES; RANDOM ALLOCATION; SHOCK, HEMORRHAGIC; SWINE; TRANSCRIPTION, GENETIC;

EID: 33747627613     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/01.ta.0000224211.36154.44     Document Type: Article

References (73)

1. Evans GH. The abuse of normal salt solution. JAMA. 1911;57:2126-2127.
2. Shires T, Coln D, Carrico J, et al. Fluid therapy in hemorrhagic shock. Arch Surg. 1964;88:688-693.
3. Hardaway RM, James PM Jr, Anderson RW, et al. Intensive study and treatment of shock in man. JAMA. 1967;199:779-790.
4. Alderson P, Schierhout G, Roberts I, et al. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2000;2:CD000567.
5. Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331:1105-1109.
6. Handrigan MT, Bentley TB, Oliver JD, et al. Choice of fluid influences outcome in prolonged hypotensive resuscitation after hemorrhage in awake rats. Shock. 2005;23:337-343.
7. Rafie AD, Rath PA, Michell MW, et al. Hypotensive resuscitation of multiple hemorrhages using crystalloid and colloids. Shock. 2004;22:262-269.
8. Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma. 2002;52:1141-1146.
9. Giannoudis PV. Current concepts of the inflammatory response after major trauma: an update. Injury. 2003;34:397-404.
10. Gurfinkel V, Poggetti RS, Fontes B, et al. Hypertonic saline improves tissue oxygenation and reduces systemic and pulmonary inflammatory response caused by hemorrhagic shock. J Trauma. 2003;54:1137-1145.
11. Rhee P, Burris D, Kaufmann C, et al. Lactated Ringer's solution resuscitation causes neutrophil activation after hemorrhagic shock. J Trauma. 1998;44:313-319.
12. de Felippe J Jr, Timoner J, Velasco IT, et al. Treatment of refractory hypovolaemic shock by 7.5% sodium chloride injections. Lancet. 1980;2:1002-1004.
13. Rizoli SB, Rhind SG, Shek PN, et al. The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial. Ann Surg. 2006;243:47-57.
14. Lee CC, Chang IJ, Yen ZS, et al. Effect of different resuscitation fluids on cytokine response in a rat model of hemorrhagic shock. Shock. 2005;24:177-181.
15. Engel JM, Welters I, Rupp M, et al. Influence of colloid fluids on polymorphonuclear granulocyte function in vivo. Acta Anaesthesiol Scand. 2001;45:385-389.
16. Jaeger K, Heine J, Ruschulte H, et al. Effects of colloidal resuscitation fluids on the neutrophil respiratory burst. Transfusion. 2001;41:1064-1068.
17. Watters JM, Brundage SI, Todd SR, et al. Resuscitation with lactated Ringer's does not increase inflammatory response in a swine model of uncontrolled hemorrhagic shock. Shock. 2004;22:283-287.
18. Koustova E, Stanton K, Gushchin V, et al. Effects of lactated Ringer's solutions on human leukocytes. J Trauma. 2002;52:872-878.
19. Todd SR, Malinoski D, Schreiber M. Hextend attenuates the hypercoagulability following severe liver injury in swine. J Trauma. 2004;56:226.
20. Dailey SE, Dysart CB, Langan DR, et al. An in vitro study comparing the effects of Hextend, Hespan, normal saline, and lactated ringer's solution on thrombelastography and the activated partial thromboplastin time. J Cardiothorac Vasc Anesth. 2005;19:358-361.
21. Roche AM, Mythen MG, James MF. Effects of a new modified balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. Br J Anaesth. 2004;92:154-155.
22. Nielsen VG. Resuscitation with Hextend decreases endogenous circulating heparin activity and accelerates clot initiation after hemorrhage in the rabbit. Anesth Analg. 2001;93:1106-1110.
23. Barron ME, Wilkes MM, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg. 2004;139:552-563.
24. Boldt J, Mueller M, Menges T, et al. Influence of different volume therapy regimens on regulators of the circulation in the critically ill. Br J Anaesth. 1996;77:480-487.
25. Moore EE, Cogbill TH, Jurkovich GJ, et al. Organ injury scaling: spleen and liver (1994 revision). J Trauma. 1995;38:323-324.
26. Holcomb JB, Pusateri AE, Harris RA, et al. Effect of dry fibrin sealant dressings versus gauze packing on blood loss in grade V liver injuries in resuscitated swine. J Trauma. 1999;46:49-57.
27. Schreiber MA, Holcomb JB, Hedner U, et al. The effect of recombinant factor VIIa on noncoagulopathic pigs with grade V liver injuries. J Am Coll Surg. 2003;196:691-697.
28. Gloster SE, Strom AD. Sus scrofa granulocyte-colony stimulating factor mRNA, complete cds. Direct Submission, NCBI, NIH, NIH. 1996.
29. Choi CS, Lin GF, Molitor TW, Murtaugh MP. Complete nucleotide sequence of a cDNA encoding porcine tumor necrosis factor-alpha. Anim Biotechnol. 1991;2:97-105.
30. Mathialagan N, Bixby JA, Roberts RM. Expression of interleukin-6 in porcine, ovine, and bovine preimplantation conceptuses. Mol Reprod Dev. 1992;32:324-330.
31. Napolitano LM, Faist E, Wichmann MW, Coimbra R. Immune dysfunction in trauma. Surg Clin North Am. 1999;79:1385-1416.
32. Molina PE, Malek S, Lang CH, et al. Early organ-specific hemorrhage-induced increases in tissue cytokine content: associated neurohormonal and opioid alterations. Neuroimmunomodulation. 1997;4:28-36.
33. Tamion F, Richard V, Lyoumi S, et al. Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am J Physiol. 1997;273:G314-G321.
34. Khadaroo RG, Fan J, Powers KA, et al. Impaired induction of IL-10 expression in the lung following hemorrhagic shock. Shock. 2004;22:333-339.
35. Gushchin V, Stegalkina S, Alam HB, et al. Cytokine expression profiling in human leukocytes after exposure to hypertonic and isotonic fluids. J Trauma. 2002;52:867-871.
36. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA. 1994;271:226-233. Review.
37. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet. 1986;1:11-14.
38. Moraes TJ, Zurawska JH, Downey GP. Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol. 2006;13:21-27. Review.
39. Pallister I, Dent C, Topley N. Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Crit Care Med. 2002;30:1717-1721.
40. Bhatia RK, Pallister I, Dent C, et al. Enhanced neutrophil migratory activity following major blunt trauma. Injury. 2005;36:956-962.
41. Ferguson KL, Taheri P, Rodriguez J, et al. Tumor necrosis factor activity increases in the early response to trauma. Acad Emerg Med. 1997;4:1035-1040.
42. Ayala A, Perrin MM, Meldrum DR, et al. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine. 1990;2:170-174.
43. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol. 2004;202:145-156.
44. Sica A, Wang JM, Colotta F, et al. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol. 1990;144:3034-3038.
45. Standiford TJ, Kunkel SL, Phan SH, et al. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem. 1991;266:9912-9918.
46. Park WY, Goodman RB, Steinberg KP. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Cit Care Med. 2001;164:1896-1903.
47. Cinat ME, Waxman K, Granger GA, et al. Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg. 1994;179:529-537.
48. Law MM, Cryer HG, Abraham E. Elevated levels of soluble ICAM-1 correlate with the development of multiple organ failure in severely injured trauma patients. J Trauma. 1994;37:100-109; discussion 109-110.
49. Foex BA, Lamb WR, Roberts TE, et al. Early cytokine response to multiple injury. Injury. 1993;24:373-376.
50. Biffl WL, Moore EE, Moore FA, Barnett CC Jr. Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor. J Trauma. 1996;40:575-578; discussion 578-579.
51. Leser HG, Gross C, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute phase response and reflects severity in acute pancreatitis. Gastroenterology. 1991;101:782-785.
52. Koj A. The role of interleukin-6 as the hepatocyte stimulating factor in the network of inflammatory cytokines. Ann N Y Acad Sci. 1989;557:1-8. Review.
53. Svoboda P, Kantorova I, Ochmann J. Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma. 1994;36:336-340.
54. Martin C, Boisson C, Haccoun M, et al. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med. 1997;25:1813-1819.
55. Roumen RM, Hendriks T, van der Ven-Jongekrijg J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg. 1993;218:769-776.
56. Pullicino EA, Carli F, Poole S, et al. The relationship between the circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymphokine Res. 1990;9:231-238.
57. Moore FA, Moore EE, Poggetti R, et al. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma. 1991;31:629-636; discussion 636-638.
58. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 1995;107:1062-1073.
59. Remick DG, Bolgos GR, Siddiqui J, et al. Six at six: interleukin-6 measured 6 hours after the initiation of sepsis predicts mortality over 3 days. Shock. 2002;17:463-467.
60. Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, the soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med. 1996;24:392-397.
61. Toth B, Yokoyama Y, Schwacha MG, et al. Insights into the role of interleukin-6 in the induction of hepatic injury after trauma-hemorrhagic shock. J Appl Physiol. 2004;97:2184-2189.
62. Brundage SI, Zautke NA, Holcomb JB, et al. Interleukin-6 infusion blunts proinflammatory cytokine production without causing systematic toxicity in a swine model of uncontrolled hemorrhagic shock. J Trauma. 2004;57:970-977; discussion 977-978.
63. Hartung T, Doecke WD, Bundschuh D, et al. Effect of folgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin Pharmacol Ther. 1999;66:415-424.
64. Hierholzer C, Kelly E, Lyons V, et el. G-CSF instillation into rat lungs mediates neutrophil recruitment, pulmonary edema, and hypoxia. J Leukoc Biol. 1998;63:169-174.
65. Jarrar D, Kuebler JF, Rue LW 3rd, et al. Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-kappaB and MAPK/ERK mechanisms. Am J Physiol Lung Cell Mol Physiol. 2002;283:L799-L805.
66. Fan J, Ye RD, Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1037-L1050.
67. Rhee P, Wang D, Ruff P. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med. 2000;28:74-78.
68. Dieterich HJ. Recent developments in European colloid solutions. J Trauma. 2003;54:S26-S30.
69. Boldt J, Müller M, Mentges D, et al. Volume therapy in the critically ill: is there a difference? Intensive Care Med. 1998;24:28-36.
70. Vincent JL. Plugging the leaks? New insights into synthetic colloids. Crit Care Med. 1991;19:316.
71. Hirani N, Antonicelli F, Strieter RM, et al. The regulation of interleukin-8 by hypoxia in human macrophages: a potential role in the pathogenesis of the acute respiratory distress syndrome (ARDS). Mol Med. 2001;7:685-697.
72. Leeper-Woodford SK, Detmer K. Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-κB expression. Am J Physiol Lung Cell Mol Physiol. 1999;276:L909-L916.
73. Jazwa A, Loboda A, Rutkowski A, et al. Macroarray analysis of hypoxia dependent angiogenic gene expression in human kerotinocytes. Eur J Biochem. 2003;1(Suppl 1):P4.1-12.